Cargando…
Retrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is an extremely infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak of this virus has resulted in significant morbidity and mortality throughout the world. We have seen an unprecedented spread of th...
Autores principales: | Choubey, Abhinav, Sagar, Diaeddin, Cawley, Philippa, Miller, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104331/ https://www.ncbi.nlm.nih.gov/pubmed/33686975 http://dx.doi.org/10.4103/lungindia.lungindia_607_20 |
Ejemplares similares
-
The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients
por: Rangroo, Rohit, et al.
Publicado: (2022) -
Concomitant infection with COVID-19 and Mycoplasma pneumoniae
por: Huang, Allen Chung-Cheng, et al.
Publicado: (2020) -
Mycoplasma pneumoniae COVID-19 Delta Variant
Co-Infection Mimicking COVID-19 ARDS
por: Crosby, James, et al.
Publicado: (2022) -
COVID‐19 pneumonia suspected to be co‐infection with Mycoplasma pneumoniae and improved by early administration of favipiravir and ciclesonide
por: Ito, Keima, et al.
Publicado: (2021) -
Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae
por: Zha, Lei, et al.
Publicado: (2020)